Aptorum Group has initiated IND-Enabling Studies for its ALS-4 Small Molecule Candidate for the Treatment of Infections Caused by Staphylococcus Aureus including MRSA
- Written by ACN Newswire
Bad Request
HTTP Error 400. The size of the request headers is too long.
Authors: ACN Newswire
Read more http://www.acnnewswire.com/press-release/english/54288/